Hostname: page-component-7b7567c8c-kwt9d Total loading time: 0 Render date: 2026-11-14T20:22:15.678Z Has data issue: false hasContentIssue false

The impact of repeated vaccination on relative influenza vaccine effectiveness among vaccinated adults in the United Kingdom

Published online by Cambridge University Press:  04 November 2022

Wey Wen Lim*
Affiliation:
WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China
Benjamin J. Cowling
Affiliation:
WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, ChinaLaboratory of Data Discovery for Health Limited, Hong Kong Science and Technology Park, New Territories, Hong Kong Special Administrative Region, China
Georgina Nakafero
Affiliation:
Academic Rheumatology, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, UK
Shuo Feng
Affiliation:
WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, ChinaOxford Vaccine Group, University of Oxford, Oxford, UK
Jonathan S. Nguyen-Van-Tam
Affiliation:
Division of Epidemiology and Public Health, School of Clinical Sciences, University of Nottingham, Nottingham, UK
Hikaru Bolt*
Affiliation:
South East and London Field Services, National Infection Service, Public Health England, London, UKDepartment of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK
*
Authors for correspondence: Wey Wen Lim, Hikaru Bolt, E-mail: wwenlim@hku.hk or wwen@connect.hku.hk, hikaru.bolt@lshtm.ac.uk
Authors for correspondence: Wey Wen Lim, Hikaru Bolt, E-mail: wwenlim@hku.hk or wwen@connect.hku.hk, hikaru.bolt@lshtm.ac.uk
Rights & Permissions [Opens in a new window]

Abstract

Annual seasonal influenza vaccination is recommended for individuals at high risk of developing post-infection complications in many locations. However, reduced vaccine immunogenicity and effectiveness have been observed among repeat vaccinees in some influenza seasons. We investigated the impact of repeated influenza vaccination on relative vaccine effectiveness (VE) among individuals who were recommended for influenza vaccination in the United Kingdom with a retrospective cohort study using primary healthcare data from the Clinical Practice Research Datalink, a primary care database in the United Kingdom. Relative VE was estimated against general practitioner-diagnosed influenza-like illnesses (GP-ILI) and medically attended acute respiratory illnesses (MAARI) among participants who have been repeatedly vaccinated compared with first-time vaccinees using proportional hazards models. Relative VE against MAARI may be reduced for individuals above 65 years old who were vaccinated in the current and previous influenza seasons for some influenza seasons. However, these findings were not conclusive as we could not exclude the possibility of residual confounding in our dataset. The use of routinely collected data from electronic health records to examine the effects of repeated vaccination needs to be complemented with sufficient efforts to include negative control outcomes to rule out residual confounding.

Information

Type
Original Paper
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
Copyright © The Author(s), 2022. Published by Cambridge University Press
Figure 0

Table 1.Characteristics of individuals included in the analyses of main outcomes and negative control outcomes for influenza seasons 2011/12 to 2015/16

Figure 1

Fig. 1.Influenza activity, cumulative vaccination coverage in the study cohorts, and rates of study outcomes in the United Kingdom from September 2011 to September 2016. Influenza seasons are indicated by areas shaded in red, while negative control periods specified in this study are indicated by areas shaded in blue in all panels. (a) Influenza activity in the United Kingdom from the 2011/12 winter influenza season to the 2015/16 influenza season based on national surveillance data. (b) Cumulative proportion of participants vaccinated over time in the study cohort each year. (c) Rates of acute respiratory illnesses and influenza-like illnesses in the study cohorts during the winter influenza seasons and negative control periods each year. (d) Rates of negative control outcomes of hip fractures (HIP) and urinary tract infections (UTI) during the winter influenza seasons and negative control periods each year.

Figure 2

Fig. 2.Estimates with 95% confidence intervals of relative VE against GP-ILIs (a), MAARI (b), hip fractures (c) and urinary tract infections (d) during influenza seasons among vaccinees who received influenza vaccination in the previous season compared with first-time vaccinees who have not received any influenza vaccination in the preceding five influenza seasons.

Figure 3

Fig. 3.Estimates with 95% confidence intervals of relative VE against MAARI during the negative control period among repeated vaccinees and first-time vaccinees. Relative VE against MAARI among vaccinees who received influenza vaccination in the previous season compared with first-time vaccinees who have not received any influenza vaccination in the previous five influenza seasons is presented in (a). Relative VE against MAARI among vaccinees who received one to five influenza vaccinations (left to right) in the previous five influenza seasons compared with first-time vaccinees who have not received any influenza vaccination in the previous five influenza seasons are presented in (b).

Figure 4

Fig. 4.Estimates with 95% confidence intervals of r elative VE against GP-ILIs (a), MAARI (b), hip fractures (c) and urinary tract infections (d) during influenza seasons among vaccinees who received one to five influenza vaccinations (left to right) in the previous five influenza seasons compared with first-time vaccinees who have not received any influenza vaccination in the previous five influenza seasons.

Supplementary material: File

Lim et al. supplementary material

Lim et al. supplementary material

Download Lim et al. supplementary material(File)
File 851 KB